Anhuienoside C Attenuates Podocyte Injury in Diabetic Nephropathy Rats. 2020

Chengjian Wang, and Yingsong Jiang, and Keping Yu, and Ke Liu, and Hao Wang
Department of Endocrinology, Chongqing General Hospital, University of Chinese Academy of Sciences, Chongqing, China.

OBJECTIVE The present study evaluated the nephroprotective effects of anhuienoside C (AC) against diabetic nephropathy (DN) in rats. METHODS Diabetic nephropathy was induced by administration of a high-fat diet (HFD) for 8 weeks and intraperitoneal administration of streptozotocin (STZ; 30 mg/kg) at the end of the fourth week of this protocol. Effects of AC on blood glucose levels, renal function markers, and mediators of inflammation in the serum of DN rats were assessed. RESULTS Anhuienoside C treatment reduced the blood glucose levels and attenuated the increased levels of renal injury markers in DN rats. Anhuienoside C also increased podocyte counts; alleviated the changes in podocin, desmin, and nephrin protein levels; and ameliorated the altered pathophysiology in the kidney tissues induced by DN. Compared with the DN group, the levels of inflammatory markers and mediators of oxidative stress were reduced in the serum and kidney tissues of the AC-treated groups. Moreover, treatment with AC ameliorates the altered expression of podocin, nephrin, and desmin proteins in the renal tissue of HFD/STZ-induced kidney-injured rats. CONCLUSIONS In conclusion, AC protected against podocyte injury by regulating nuclear factor kappa-light-chain-enhancer of activated B cells/protein kinase B pathway in a rat model of DN.

UI MeSH Term Description Entries

Related Publications

Chengjian Wang, and Yingsong Jiang, and Keping Yu, and Ke Liu, and Hao Wang
January 2022, Frontiers in pharmacology,
Chengjian Wang, and Yingsong Jiang, and Keping Yu, and Ke Liu, and Hao Wang
January 2002, Laboratory investigation; a journal of technical methods and pathology,
Chengjian Wang, and Yingsong Jiang, and Keping Yu, and Ke Liu, and Hao Wang
September 2013, Nature reviews. Nephrology,
Chengjian Wang, and Yingsong Jiang, and Keping Yu, and Ke Liu, and Hao Wang
January 2020, Frontiers in genetics,
Chengjian Wang, and Yingsong Jiang, and Keping Yu, and Ke Liu, and Hao Wang
August 2015, European journal of pharmacology,
Chengjian Wang, and Yingsong Jiang, and Keping Yu, and Ke Liu, and Hao Wang
May 2021, Annals of translational medicine,
Chengjian Wang, and Yingsong Jiang, and Keping Yu, and Ke Liu, and Hao Wang
April 2007, Naunyn-Schmiedeberg's archives of pharmacology,
Chengjian Wang, and Yingsong Jiang, and Keping Yu, and Ke Liu, and Hao Wang
October 2022, Journal of molecular medicine (Berlin, Germany),
Chengjian Wang, and Yingsong Jiang, and Keping Yu, and Ke Liu, and Hao Wang
July 2008, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Chengjian Wang, and Yingsong Jiang, and Keping Yu, and Ke Liu, and Hao Wang
May 2018, Journal of the American Society of Nephrology : JASN,
Copied contents to your clipboard!